Filing Flows › Tenon Medical (TNON) › R&D spending
Tenon Medical (TNON) R&D spending by quarter
Tenon Medical's R&D spending was $768K in Q2 2026 (second quarter 2026), +16% from Q1 2026. Over the last 7 quarters it ranged from $428K (Q3 2025) to $768K (Q2 2026).
| Quarter | R&D spending | Q/Q | Y/Y |
|---|---|---|---|
| Q2 2026 | $768K | +16% | +53% |
| Q1 2026 | $662K | +26% | -4% |
| Q4 2025 | $527K | +23% | -7% |
| Q3 2025 | $428K | -15% | — |
| Q2 2025 | $503K | -27% | — |
| Q1 2025 | $691K | +21% | — |
| Q4 2024 | $569K | — | — |
Q2 2026 at a glance
Tenon Medical, Q2 2026: revenue $1.3M (+127% year over year), operating margin -262.2%, net loss $4.0M, operating cash flow −$2.8M. The chart follows the revenue to costs, profit and cash.
Questions
What is Tenon Medical's R&D spending?
Tenon Medical's R&D spending was $768K in Q2 2026 (second quarter 2026), +16% from Q1 2026.
How has Tenon Medical's R&D spending changed?
Over the last 7 quarters it ranged from $428K (Q3 2025) to $768K (Q2 2026).